Original Research
Published on 15 May 2026
Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity in vitro
in Cancer Immunity and Immunotherapy
- 385 views